Delivery Order SPE2DB24D8002-SPE2DB25FJNTE
- Not listed
- The Defense Logistics Agency awarded a $2,125.75 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Drospirenone-EE 3-0.02 mg tablets (28-count). The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001)...
- Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, was awarded a delivery order on August 27, 2025, for Drospirenone-EE 3-0.02 mg tablets (28-count packages) under a firm fixed-price contract valued at $1,724.18. The Defense Logistics Agency, an arm of the U.S. Department of Defense, issued this unrestricted award with an ultimate completion date of August 28, 2025. This delivery order is issued under Dakota Drug's larger Indefinite Delivery Contract...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,659.57, is for the delivery of drospirenone-EE 3-0.02 mg tablets (28 count) and has a performance period through June 20, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a significant $999,999,999.00 Indefinite Delivery Contract (IDC) under the...
- The Defense Logistics Agency awarded a delivery order valued at $3,869.41 to Dakota Drug, Inc. for Microgestin FE 1-20 tablets (28-count) on November 5, 2025, with completion scheduled for November 6, 2025. Dakota Drug, a self-certified small disadvantaged business headquartered in Anoka, Minnesota, has been a federal contractor since June 2001 and specializes in pharmaceutical and medical equipment procurement for defense healthcare operations. This delivery order was issued without a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,230.94 to Dakota Drug, Inc. on September 23, 2025, for the supply of Cryselle-28 tablets. This firm fixed price delivery order will be completed by September 24, 2025, and will be performed in Anoka, Minnesota. The award carries no set-aside designation and represents a continuation of the DLA's medical supply procurement activities through existing contract vehicles. Dakota Drug, Inc., a self-certified small...
- The Defense Logistics Agency awarded a delivery order valued at $1,399.60 to Dakota Drug, Inc. for the supply of Cryselle-28 tablets on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order represents a pharmaceutical procurement supporting U.S. Armed Forces medical operations. The award was issued without a set-aside designation and is being performed in Anoka, Minnesota, where Dakota Drug, Inc. is headquartered. The vendor, a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,717.22 to Dakota Drug, Inc. for the supply of YAZ 28 Tablet contraceptive medication on October 30, 2025, with an ultimate completion date of October 31, 2025. This firm fixed-price delivery order, executed with no set-aside designation, represents a routine pharmaceutical procurement to support U.S. Armed Forces medical operations. The work will be performed in Anoka, Minnesota, where Dakota Drug maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,683.80 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota, for the supply of Xulane 150-35 mcg/day contraceptive patches (3-unit quantity). The contract is a firm fixed price delivery order with an ultimate completion date of September 9, 2025, and represents performance under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT...
- The Defense Logistics Agency awarded a $2,122.94 delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of eluryng vaginal rings. The contract, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is executed under Dakota Drug's larger Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,003.71 to Dakota Drug, Inc., a small disadvantaged business based in Anoka, Minnesota, for the supply of Premarin 0.625 mg tablets (100-count units). The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, operates under a firm fixed-price delivery order structure with no set-aside designation. This award falls under Dakota Drug's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB24D8002Indefinite Delivery Contract
- SPE2DB24D8002-SPE2DB25FJNTEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,625.23 to Dakota Drug, Inc., a self-certified small disadvantaged business based in Anoka, Minnesota, for the supply of Drospirenone-EE 3-0.02 mg tablets in quantities of 28 units. This firm fixed-price delivery order, issued on May 20, 2025, with an ultimate completion date of May 21, 2025, carries no set-aside designation and represents work performed at the contractor's Anoka location. Dakota Drug, Inc. leverages its position as a key pharmaceutical supplier under a larger $999,999,999 Indefinite Delivery Contract (SPE2DB24D8001) with DLA Troop Support Medical's ECAT Generation V Program, which runs through December 31, 2025, to fulfill critical medical supply needs for U.S. Armed Forces healthcare operations. Dakota Drug, Inc. has established itself as a strategic vendor within the federal medical procurement marketplace since its SAM.gov registration in 2001, demonstrating extensive capabilities in delivering a comprehensive range of pharmaceutical products and medical supplies to defense healthcare facilities. The company's contract portfolio with the Defense Logistics Agency reflects its critical role in supporting military medical operations through the delivery of diverse medications spanning diabetes management, respiratory treatments, pain management, hormonal therapies, cardiovascular prescriptions, and vaccines. This delivery order for hormonal contraceptive tablets exemplifies the vendor's ongoing support of military healthcare requirements through efficient supply chain delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 5/20/25 |